Unknown

Dataset Information

Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis.


ABSTRACT:

Background

Post-stroke depression (PSD) occurs in approximately one third of stroke survivors, leading to great disability and mortality. As there is no consensus on the optimal pharmacological treatment for PSD, we aimed to evaluate the relative efficacy and tolerability of the available pharmacological interventions.

Materials and methods

We did a network meta-analysis to incorporate evidence from relevant trials providing direct and indirect comparisons. We searched PubMed, the Cochrane Library Central Register of Controlled Trials, Embase and the reference lists of relevant articles up to March, 2017 for randomized controlled trials (RCTs), for different pharmacotherapies of PSD. For efficacy analysis, the primary outcome was the mean change in Hamilton Depression Scale

SUBMITTER: Deng L 

PROVIDER: S-EPMC5955092 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature